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Abstract 
 
We review current thinking about, and draw connections between, brain energetics and 
metabolism, mitochondria and traumatic brain injury. In addition to summarizing current 
thinking in these disciplines, our goal is to suggest a framework for mechanisms and 
pathways based on optimal energetic decisions.  	  General	  Introduction	  	  
As neuroscience makes rapid progress in mapping causes and effects at subcellular, 
cellular, tissue and system levels, the time may be ripe for increased efforts at the 
mathematical modeling of these causes and effects. Descriptive understanding is 
extremely valuable, but these tend to be snapshots of coupled and time-dependent 
processes simultaneously governed by dozens of parameters. Mathematical models, 
where possible, offer dynamical equations that govern these coupled time-dependent 
(and perhaps space-dependent) parameters, some if not all of which are stochastic in 
nature, and apparently sensitive to parameter variations. While these possible 
mathematical equations are data-dependent, they are not data-driven. They permit 
computational analysis, parameter variations, and sensitivity analyses. They can be 
used to estimate the outcomes of clinical interventions, and for experimental design, 
perhaps reducing the number of these in time. This review suggests opportunities for 
such mathematical models where optimal decisions are apparently made in certain 
energetic pathways. 
 Whereas neurons and glia are the components of brain function, energy 
homeostasis must be maintained to assure proper functioning. This homeostasis is the 
product of metabolic reactions that are coupled to energy demands in space and time 
throughout the brain, and regulated by feedforward and feedback mechanisms. The 
mitochondria are at the center of this universe, providing up to about 95% of this 
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energy, where and when it is in demand in the central nervous system. Any mismatch 
between supply and demand over a significant time interval invariably initiates cascades 
of dysfunction leading to well-known neurodegenerative and neuropsychiatric 
pathologies. Energy is the currency of brain function, and is likely the basis for the 
physiological or pathological pathway decisions taken. 
 This paper summarizes our current understanding of the coupling between brain 
energetics (and metabolism), the mitochondria, and traumatic brain injury. Our summary 
is unavoidably selective given the vast literature in all these fields. We have tried to 
capture an essence of what present-day primarily experimental evidence implies 
regarding these functions. Some hypotheses are suggested intermittently and at the 
end of the paper. 	  Energetics	  	  
1. Introduction 
Among placental animals, human brain size relative to body size is the largest [Gibbons 
1988]. Brain activity requires significant energy. To understand brain functioning, 
cellular and molecular mechanisms of brain activity need to be identified and coupled to 
energy metabolism. This approach has been understood for over a century [Magistretti 
et al 1999] due to the tight coupling between neuronal activity and energy metabolism. 
Imaging technologies have permitted this mapping. Magistretti and Pellerin [1999] 
propose what came to be known as the astrocyte-neuron lactate shuttle hypothesis 
(ANLS), where lactate may be the preferred energy substrate of activated neurons 
under aerobic conditions. To this day there are debates on this hypothesis, and these 
will be introduced as we proceed. Key components of the above-mentioned coupling 
are the neurotransmitter glutamate and astrocytes, a glial cell. Chih et al [2001] pick up 
the discussion on the so-called astrocyte-neuron lactate shuttle, where glial energy 
needs are met by anaerobic glycolysis, while neuronal metabolism is fueled by lactate 
released from the glia during neuronal activity. Based on enzyme kinetics and substrate 
availability, it is suggested that neurons likely use ambient glucose as the major 
substrate during activity rather than glial-derived lactate. Furthermore, it is possible that 
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lactate might be used after neural activity when glycolytic rates slow, and during 
recovery from pathological insults. This possibility may be tied to glial behavioral 
changes after traumatic brain injury. Magistretti and Allaman [2016] provide an updated 
overview. 
 As discussed in detail subsequently, a key component of the neuronal energy 
equation is the organelle, the mitochondrion. As we find out, mitochondria transport to 
locations within the cell where energy is required. For the neuron, this means that it 
must ensure an adequate supply and distribution of mitochondria that are healthy and 
functional throughout its axon and dendritic arborizations. Given the morphological 
complexity of these cells, and that neuronal function is closely coupled with glial cells, it 
is possible that evolutionarily conserved optimization mechanisms have significant roles 
in assuring sufficient energy as needed. 
 
2. Astrocytes 
Astrocytes possess specialized processes that cover the surface of intraparenchymal 
capillaries, where they can control glucose uptake, as well as processes that wrap 
around neuronal synapses, sites of receptors and reuptake of neurotransmitters. Such a 
strategic presence allows astrocytes to sense synaptic activity and couple these with 
energy metabolism. A review of energy metabolism in astrocytes by Hertz et al [2007] 
underscores their importance to brain function. Primary roles are astrocytic interactions 
with the vasculature, neurons, and other astrocytes via signaling, the regulation of blood 
flow, the modulation of impulse transmission, and the synthesis and degradation of 
glucose-derived neurotransmitters, which modulate local energy metabolism in the 
brain. All these roles are dependent on a connection to various metabolic pathways, 
thus coupling astrocytic functions to energetics and metabolic fluxes. It is noted that 
under rest conditions, astrocytes account for approximately 30% of oxidative 
metabolism in the brain and about 50% of glycolysis, but very little glycogenolysis. This 
suggests that there are functional activities that are not known or fully understood. Any 
disruption of these processes rapidly alters neuronal function, suggesting mechanisms 
for gliosis after brain insult. 
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The typical astrocyte cell volume is mostly distributed in the processes, with about 2% 
of the volume in the cell body and about 60% for the organelle-containing processes. 
Oxidative capabilities rest within the cell body and larger cell processes that contain the 
mitochondria. The remaining almost 40% of astrocytic volume is contained in the 
threadlike filopodia, and sheet-like lamellipodia, which are highly mobile but cannot 
generally accommodate mitochondria, which are about twice as wide (although there is 
evidence that mitochondria exist in the fine astrocytic processes). However, these small 
extensions respond rapidly to increases in energy demand via glycolytically-derived 
ATP [Hertz et al 2007].  
Understanding how neurons and astrocytes regulate blood flow is evolving, as 
this knowledge is critical to the ability to develop new therapeutic approaches. It 
appears that neurotransmitter-mediated signaling, in particular by glutamate, rather than 
energy use, has a key role in regulating cerebral blood flow, where astrocytes play a 
key role. It is significant that astrocytes take up over 90% of the glutamate released as a 
neurotransmitter. If this did not occur, and the glutamate was taken away by the blood, 
then the glucose supply to the brain would have to be approximately doubled in order to 
supply the carbon skeletons needed for glutamate synthesis, as well as the glucose 
needed as a substrate for ATP production [Nortley and Attwell 2017]. Signaling pathway 
differences can lead to different blood flow control in various brain areas, and this 
control occurs at the capillary and arteriole levels, where O2 concentrations regulate the 
relative importance of the signaling pathways involved [Attwell et al 2010].  
Peppiatt and Attwell [2004] report on the importance of astrocytes to blood flow 
regulation. These glial cells simultaneously surround neurons with their cell membrane 
and have extensions, called endfeet, close to capillaries. A rise in calcium levels may 
either dilate or constrict arterioles and increase or reduce local blood flow, depending on 
other factors at play.  
There are approximately as many astrocytes as there are neurons in the brain. 
Astrocyte processes cover approximately 63% of capillaries, with the remaining area 
almost covered by pericytes, which are spatially isolated contractile cells that are 
believed to be responsible for a major fraction of increased blood flow [Nortley and 
Attwell 2017]. It has been implied that low levels of neuronal activity lead to an increase 
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in blood flow solely by dilating arterioles (possibly mediated by NO without intercession 
by either astrocytes or pericytes), while higher activity also dilates capillaries via 
astrocytes and pericytes. That glycolysis in not purely astrocytic, and that lactate-fuelled 
oxidative phosphorylation is not purely neuronal, removes some of the basis for the 
ANLS hypothesis, but there are no firm conclusions to date [Nortley and Attwell 2017]. 
Escartin et al [2006] review the contributions of NMR to astrocyte-neuron 
coupling in the regulation of brain energy metabolism. The dialogue between astrocytes 
and neurons is a critical aspect of proper brain function. The brain has significant and 
continuous energy needs and, especially in periods of high activity and therefore 
demand, it is highly vulnerable to a drop in supply, that is, energetic dysfunction, and 
dysfunction of homeostasis. Such dysfunction, as well as improper recycling and 
metabolism of glutamate, are at the core of numerous chronic neurodegenerative 
diseases, in particular the big-four diseases (APHALS): Alzheimer’s, Parkinson’s, and 
Huntington’s, and amyotrophic lateral sclerosis (ALS). 
 Astrocytes have been found to be a central player in brain function on many 
levels. In addition to supporting neuronal function through the supply of energy 
metabolites and by recycling neurotransmitters, they play a central role in brain 
homeostasis (including during sleep). That is, glutamate, ion and water homeostasis, 
oxidative stress defense, energy storage as glycogen (that can be rapidly metabolized 
without ATP), scar formation and tissue repair (as a response to insult and traumatic 
brain injury), release of gliotransmitters for synaptic activity modulation, and synaptic 
formation and remodeling (plasticity). Additionally, they have roles in memory 
consolidation and the regulation of breathing. Astrocytes are a morphologically 
heterogeneous population, with a variety of receptors, ion channels and proteins. In 
some instances their effects are negative, as in reactive astrogliosis and the formation 
of a glial scar, where the fine line between neuroprotection and neurotoxicity is not well 
understood. Given the importance of astrocytes on metabolic function, and that 
metabolic dysfunction has been shown to lead to neurodegenerative disorders, a 
deeper understanding of astrocytes and their couplings is critical for the development 
and implementation of clinical interventions [Allaman et al 2011]. One metabolic 
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susceptibility is the appearance of astrocytoma cells, which are the most common types 
of cancer in the brain, and the most common gliomas [Turner and Adamson 2011]. 
 Astrocytic gap-junctions appear to be crucial to the central role of astrocytes to 
neurometabolic coupling [Escartin and Rouach 2013]. The power of such coupling is not 
at the individual neuro-glia-vascular unit, but rather based on the networks of astrocytes 
connected by gap junctions. Thus, models of astroglial metabolic support of neuronal 
activity must encompass the gap-junction-mediated astroglial networks. (Similarly, 
networks of mitochondria can work as a group rather than as individual mitochondria.) 
Such a modeling perspective more accurately reflects their influence over local 
synapses, as well as distal neuronal circuits. This is useful since optimal metabolic 
pathways are chosen for proper energetic functioning as well as the minimization of 
energy expenditures. This approach is strongly suggested by the likelihood [Escartin 
and Rouach 2013] that metabolic waves pass through astroglial networks in both 
physiological and pathological conditions, enforcing metabolic coupling over extensive 
distances. The significance of astrocytic gap junctions has been understood for some 
time [Scemes and Spray 2004]. Such gap junctions between astrocytes provide 
pathways for direct intercellular exchanges of ions, nutrients and signaling molecules. 
Additionally, such pathways may be a part of the machinery for delivering nutrients to 
neurons, removing excess K+ and glutamate from intercellular space, spreading 
intercellular Ca++, and exchanging cell death signals. Gap junction connected astrocytes 
may be viewed as a hybrid between cellularized individual cells and syncytial cells, that 
is, a functional syncytium. They are individual cells, but are connected via the gap 
junctions that coordinately and cooperatively react to long-range neuronal activity and 
environmental stimuli.  
Such coordination and cooperation requires biochemical energetic “choices” that 
are optimum in some sense, either minimizing energy cost, or maximizing speed, or 
some combination of these. Furthermore, it is possible that reflexive (autaptic) gap 
junctions in astrocytes can alter gap junction coupling strength so as to isolate or 
integrate microdomains in order to fine tune molecular transport throughout the 
astrocytic network in response to neuronal activity. This appears to correlate with the 
view [Barros 2010 discussed below] that to maintain steady brain energy use, regions of 
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active cells may be surrounded by passive cells, thus localizing energy use as needed. 
Gap junction permeability and selectivity modulation play roles in these dynamic 
mechanisms. Such dynamics can only be efficiently captured by mathematical models 
that are representative of time- and space-dependence of mechanisms. 
 In pathological conditions, gap-junction-mediated networks of astrocytes can 
contribute to the transfer of survival signals, such as metabolic substrates, in situations 
where local acute pathological conditions occur in which distal neurons are no longer 
connected to the bloodstream. Examples include ischemia, traumatic brain injury, or 
infections [Escartin and Rouach 2013], in cases where the gap-junction channels are 
still functional. 
 As one of the foremost proponent of the importance of glial cells, Barres’ [2008] 
makes a critical point in his poignant paper: “Quite possibly saving astrocytes from 
dying in neurological disease would be a far more effective strategy than trying to save 
neurons (glia already know how to save neurons, whereas neuroscientists still have no 
clue).” Neuroenergetics is now a study of integrated astrocyte-neuron systems where 
cooperation and complementary functions are critical for brain health [Bélanger et al 
2011, Bouzier-Sore and Pellerin 2013]. Astrocytes have a role in higher cognitive 
functions, and therefore contribute to the pathogenesis of several brain disorders [Dossi 
et al 2018]. Neuron-astrocyte network computational models are valuable in silico 
representations [Oschmann et al 2018]. 
 
3. Mathematical Modeling 
The mathematical modeling of energetics and metabolism started in earnest with the 
availability of imaging data. One such effort by Aubert et al [2001] models brain 
functional imaging using a system of differential equations that govern the following 
processes that are involved in brain activation: (1) sodium membrane transport, (2) 
Na/K ATPase, (3) neuronal energy metabolism (i.e., glycolysis, buffering effect of 
phosphocreatine, and mitochondrial respiration), (4) blood-brain barrier exchanges, and 
(5) brain hemodynamics. The purpose of these mathematical models is to enable the 
interpretation of MRS and fMRI data. Brain activation and metabolism are assumed to 
be coupled due to either changes in ATP and ADP concentrations following activation of 
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Na/K ATPase resulting from changes in ion concentrations, or the involvement of a 
second messenger such as calcium. Physiological interpretations are challenging. The 
above-mentioned differential equations are typically first-order rate equations. Aubert 
and Costalat [2002] additionally model the coupling between brain electrical activity, 
metabolism, and hemodynamics. These models help us with a better interpretation of 
functional brain imaging signals, as well as possibly relating these activities to brain 
diseases. These approaches are explored by Aubert et al [2002] for gliomas, which can 
display significant changes in concentrations of energy metabolism molecules.  
Aubert and Costalat [2005] continued the exploration of the ANLS framework 
using a mathematical model of the energy metabolism that couples neurons and 
astrocytes. Their model suggests possible physiological mechanisms where ANLS is 
compatible under certain conditions with the classical view of brain metabolism. Aubert 
et al [2005] continue the mathematical modeling of brain lactate kinetics, that 
intraparenchymally formed lactate can be a significant energy substrate for neurons. 
Their model predicts that neurons are lactate-consuming cells while astrocytes are 
lactate-producing cells; in agreement with in vivo observations, such production and 
activation increase in a coupled way. In a continuation of their mathematical modeling of 
metabolic pathways and the study of the role of lactate in the relationship between 
astrocyte and neuron, Aubert and Costalat [2007] examine compartmentalization of 
brain energy metabolism, with Aubert et al [2007] providing a functional neuroimaging 
perspective. They discuss possible modifications of the functional relationships between 
glia and neurons upon activation, and under what conditions the ANLS hypothesis can 
work, noting that in order to understand brain energy metabolism a thorough model of 
the interactions between neurons and glia is fundamental. 
Vatov et al [2006] construct and test a mathematical model of brain energy 
metabolism that incorporates the following parameters: cerebral blood flow, partial 
oxygen pressure, mitochondrial NADH redox state, and extracellular potassium. It aims 
to reproduce pathological conditions, such as complete and partial ischemia, and 
cortical spreading depression. This is a point-model, where only variability in time is 
calculated, not in space, with the potential to describe pathogenesis of tissues in various 
experimental and clinical situations. 
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4. Energy Expenditures 
The brain depends on glucose as its primary fuel due to the selective permeability of the 
blood-brain barrier. Glucose cannot be replaced as an energy source, but it can be 
supplemented during high levels of physical activity or during starvation. Neuroactive 
compounds such as glutamate, aspartate, and glycine, as well as other compounds 
required by the brain to function that cannot pass through the blood-brain barrier, need 
to be synthesized from glucose within the brain. Approximately 5.6 mg of glucose is 
consumed per 100 g of human brain tissue per minute. While action potentials are 
evolutionarily efficient, much of the energy used in the brain is used on synaptic activity; 
the human cortex requires approximately 3x1023 ATP/s/m3, and the energy expenditure 
to release one synaptic vesicle is calculated to be approximately 1.64x105 molecules 
ATP  [Mergenthaler et al 2013]. 
Attwell and Laughlin [2001] present detailed calculations of energy expenditures 
on different cellular mechanisms in the brain. While the human brain is 2% of the body’s 
weight, it demands 20% of the body’s resting metabolic output, that is, glucose-derived 
energy. Action potentials and postsynaptic effects of the neurotransmitter glutamate are 
estimated to consume much of that energy, 47% and 34%, respectively. The resting 
potential requires 13%, and glutamate recycling requires 3%. It is clear that the action 
potential rate has a significant effect on energy usage, and is, in this paper, tied to 
oxygen consumption rates. Various other energy consumption rates are provided in 
considerable detail.  
Laughlin and Attwell [2004] update their earlier energy budget. Postsynaptic 
energy consumption dominates the cost of synaptic transmission, roughly 85%. That 
mitochondria are concentrated around synapses, in dendrites and presynaptic 
terminals, is consistent with the view that synapses require much more energy than 
action potentials. The variety of homeostatic mechanisms required to reset ionic 
gradients after neural signaling require energy produced by the hydrolysis of ATP to 
ADP, where most of the brain’s ATP is regenerated from ADP by the aerobic glycolysis 
of glucose. Interestingly, it is noted that synaptic costs can only be probabilistically 
characterized for the following reasons. There is a large variance in the number of 
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postsynaptic ion channels activated by the release of a vesicle of neurotransmitter, and 
this can vary between synapses. Secondly, the proportion of synapses that release 
neurotransmitter in response to an action potential is a function of signaling history, and 
also has variance. This is discussed further subsequently. 
 In the same paper, Laughlin and Attwell provide interesting perspectives on the 
efficiencies and optimalities in the evolved brain. This involves reduced metabolic costs 
of signal transmission and synaptic transfer, and these initiated by as few action 
potentials as necessary to transmit the minimum information needed for effectiveness. 
In fact, synapses save large amounts of energy by reducing the probability of 
transmitter release to a number far below 1 (discussed below). The cortex can be 
metabolically efficient by using synaptic plasticity to ensure that every transmitted signal 
delivers significant information to the postsynaptic neuron. An updated energy 
distribution approximates 60% for signaling and 40% for housekeeping, which includes 
processes such as lipid turnover, mitochondrial proton leak and actin treadmilling [Engl 
and Attwell 2015]. 
Counter-intuitively, Raichle and Gusnard [2002] point to the fact that the high rate 
of metabolism is essentially constant despite widely varying mental and motor activity. It 
is suggested that the brain’s baseline use of energy is generally high, and a large 
amount of this metabolic activity is focused on maintaining a balance between excitatory 
and inhibitory activity by ongoing synaptic processes. They note that brain activation 
distinguishes itself from ongoing brain metabolism, where blood flow and glucose 
utilization increase faster than oxygen consumption. Coupling between cerebral blood 
flow (CBF) and cerebral metabolic rate of oxygen (CMRO2) during cerebral activation is 
controversial [Valabrègue et al 2003], and are major determinants of the contrast in 
fMRI. Here, the modeling assumes a relaxation of the tight coupling between CBF and 
CMRO2, allowing equations more flexibility to reflect experimental results. 
A neuronal hypothesis suggests that astrocytes communicate neuronal energy 
demand to the vasculature in two ways, resulting in vasodilation by a feedforward 
signaling mechanism allowing for fast adaptation in anticipation of uneven energy 
requirements, as well as by metabolism-dependent mechanisms that react to energy 
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requirements, but after the fact and therefore slower [Mergenthaler et al 2013, Howarth 
2014]. 
 While the metabolic rate of the brain is relatively constant, hard exercise does not 
significantly increase its overall fuel consumption, and sleep only reduces its metabolic 
rate by about 15% [Barros 2010]. However, the metabolic rate of individual neurons can 
vary significantly, requiring as much as multiples of 30-100 in fuel demand, depending 
on the neuron. The contrast between organ-level and cell-level demands might be 
attributable to a temporal averaging mechanism. It is suggested that the architecture of 
the tissue is such that active cells are surrounded by inactive cells that remain passive. 
Thus the global energy requirements can be managed at the nominal value. Based on a 
diffusion scale argument, Barros sets the maximum size of a metabolic unit in the brain 
tissue within which there is spatial averaging to be about 1 mm.  
  
5. Glucose Dynamics 
A “bottom up” model of glucose dynamics in the brain is developed by Barros et al 
[2007] beginning with known microscopic properties of the GLUT transporters. Most of 
the brain’s ATP turnover focuses on feeding neuronal Na+ pumps during signaling. 
Cloutier et al [2009] suggest that cellular energetic requirements drive energy 
metabolism, given that many of the kinetic parameters of such metabolism are the least 
sensitive parameters in their model. They further provide support for the ANLS 
hypothesis. This is also proposed by Hitze et al [2010] where the brain acts “selfishly” 
via a cerebral demand mechanism to preserve brain mass even during inanition. Such a 
“brain-pull” mechanism is critical for survival given the high energy demands of the 
brain. The brain’s need, supply, and demand for energy are increased by stress. The 
selfish brain theory is also mathematically modeled by Gödel et al [2010] in a five-part 
model.  These are: cerebral ATP, the energy in the body periphery (glucose, glycogen), 
blood glucose, insulin concentration as feedback signal of the brain, and ingestion 
regulation. This model consists of energy fluxes between compartments and signals 
directing energy fluxes, with the model providing a realistic qualitative energy 
metabolism behavior.  
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Jolivet et al [2009] introduce a “top-down” approach that utilizes datasets of 
average glucose and oxygen utilization in the brain at different activation states. Their 
analysis suggests that astrocytes take up a significant amount of glucose while primarily 
neurons consume oxygen. Such utilizations increase with increased activation, with 
astrocytes taking up more glucose than can be oxidized while neurons oxidizing more 
glucose-derived metabolites than the amount of glucose they take up, suggesting a 
transfer of glucose-derived metabolites from the astrocytes to the neurons, consistent 
with the astrocyte-neuron lactate shuttle (ANLS). Given that different cell types have 
different metabolic profiles, the above implies that there exist a broad and deep set of 
signaling mechanisms that regulate and coordinate these metabolic processes 
[Magistretti and Allaman 2015]. 
 Barros and Deitmer [2010] continue the discussion and debate regarding the so-
called astrocyte-neuron lactate shuttle. The mechanism put forward is that astrocytes 
take up glucose, transform much of it to lactate, which is then exported into neurons to 
be oxidized. They point to evidence that lactate acts as a signaling molecule involved in 
Na+ sensing and in glucosensing, and it also couples metabolic activity to the 
modulation of vascular tone in the brain. But it also appears that it is not possible to 
definitively state the source cell or the sink cell for lactate, and perhaps even for 
glucose, since both are exchanged between adjacent regions of the neuropil via the 
interstitial space. Neurons are better suited to endure fuel shortages than other cells, 
including astrocytes, can react to their own increases in demand, and are better 
equipped to take up fuels than to release them. Neuron glucose transport capacity is 
about 12 times that of astrocytes, although this does not necessarily correlate with high 
metabolic rate. A conclusion is that there may not be “typical” neurons or astrocytes. 
Rather, there is a spectral range of such cells, implying that energy problems are solved 
locally via a spectrum of strategies. Support is provided by Mächler et al [2016] who 
point to in vivo evidence of a lactate gradient from astrocytes to neurons, which is a 
prerequisite of a lactate shuttle in that direction.  And yet there is debate since there are 
several lines of evidence that neuron synapses rely on local glycolysis, that is, glycolytic 
enzymes, to rapidly metabolize glucose to provide fuel for key steps in synaptic vesicle 
recycling during synaptic activity [Ashrafi and Ryan 2017]. ANLS might be a backup 
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during periods of reduced carbon supply. An understanding of presynaptic and axonal 
metabolism is critical, as it appears clear that dysregulation of neuronal energetics is 
linked to neurodegeneration.  
 While most energetics studies of brain matter have focused on grey matter, 
Harris and Attwell [2012] have calculated the energetics of white matter. White matter 
(~50%+ of brain volume) comprises mainly of myelinated axons, while grey matter 
(~50%- of brain volume) few myelinated axons. Grey matter contains most of the 
neuron somas while white matter is made up mostly of myelinated axons. Grey matter is 
made up of nerve cell bodies, and white matter is made up of fibers. Neurons of white 
matter have extended axons while grey matter neurons do not. It was found that the 
primary reason that white matter uses less energy than grey matter is that there are 
very few synapses, not due to the presence of energetically efficient myelinated axons. 
Additionally, the oligodendrocytes that create the myelin sheath for the axons require 
ATP to maintain their resting potential, are an addition to the energy budget, and that 
energetic cost is greater than the savings accrued due to the myelinated sheaths. In 
summary, the energy use of white matter is 3-fold lower than gray matter mainly 
because it has an 80-fold lower density of synapses.  
Synaptic energy use, especially the requisite return to homeostasis after synaptic 
transmission, is a critical component of understanding brain energetic dysfunction and 
how these lead to neuropathology [Harris et al 2012]. There are a number of interesting 
and counterintuitive results. A cortical neuron receives about 8,000 synapses on its 
dendritic tree on average, and cannot possibly transmit all this information through its 
output axon. Thus, as a way to minimize energy use, there are an optimal number of 
synaptic transmissions, implying a low release probability, as mentioned earlier. There 
is an inverse relationship between release probability and release sites. The failure of 
synaptic transmission reduces this energy waste. The high energy demands at pre- and 
post-synaptic junctions places a large number of mitochondria and ATP production at 
these sites. Any disruptions to mitochondrial trafficking or function will definitely affect 
synaptic functioning, and lead to neurodegenerative diseases. An example, one of 
many, is the sensitivity of dopamine neurons to degeneration in Parkinson’s disease 
[Pissadaki and Bolam 2013], possibly due to their orders of magnitude larger 
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unmyelinated axonal arbor. Due to the resulting very high energy demand, such 
neurons are at risk of cell death when any stressor causes an excess in energy demand 
over supply. 
 Glutamate is considered to be the most important neurotransmitter in mammals. 
Its transport not only coordinates excitatory signaling needed for essentially all motor, 
sensory, and autonomic processing, but also plays a pivotal role in regulating brain 
energetics [Robinson and Jackson 2016]. Glutamate transport is both dependent on 
mitochondrial function, and is a regulator of mitochondrial function. It has been 
demonstrated that mitochondria are present in fine astrocytic processes, and they 
redistribute to provide a local source of ATP. Between 15% and 30% are mobile. A 
deep understanding of the coupling between brain energetics, mitochondria, and 
astrocytes can provide opportunities for therapeutic interventions in those instances 
when dysfunction occurs on any level. Neurometabolic couplings, mechanisms where 
astrocytes adjust energy production to meet neuronal energy needs, are particularly 
important when neurons undergo rapid changes in their firing rates, as during 
sleep/wake transitions [Petit and Magistretti 2016]. Interestingly, brain energetic 
expenditures during non-rapid eye movement sleep decreases only to about 85% of the 
waking value [DiNuzzo and Nedergaard 2017], confirming our prior discussion that the 
metabolic rate of the brain as a whole remains relatively constant whether the body is in 
hard exercise or in sleep.  Even though the purpose of sleep is not fully understood, 
given the adverse effects of sleep deprivation, it is clearly needed. Important effects 
include plasticity of neuronal networks, homogenization of neuronal spiking rates, and 
clearance of brain lactate through the glymphatic system. 
 Glucose, glycogen and lactate are viewed as the metabolic trinity that couples 
astrocytes and neurons, not only ensuring functional brain energetics but also ATP 
turnover, astrocytic signaling, memory consolidation, and gene expression. The ANLS 
hypothesis is disputed, since how lactate is generated and used is a function of activity 
level. That is, exercise drives lactate into all brain cells, becoming an oxidative fuel, and 
spares glucose for cells, such as neurons, that almost exclusively rely on that source. 
Disruption of transport or metabolism of any of the triad results in changes in the 
activities of the other two [Dienel 2017]. Furthermore, there is a broader understanding 
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of neuronal metabolic versatility, where brain cells can use fatty acids and ketone 
bodies for energy metabolism, as well as glucose and lactate. Neurons are completely 
capable of glucose uptake and glycolysis to sustain brain activity during brain 
stimulation, without any need for astrocytes or astrocyte-derived metabolites [Tang 
2018]. Acetate, an alcohol by-product formed in the liver, can also be an alternative fuel 
for the brain, but can only be metabolized by astrocytes, not neurons. Under normal 
resting conditions, acetate can provide approximately 10%-15% of the energy demand 
of brain astrocytes. Monocarboxylate transporters most likely mediate glia-axon 
metabolic interactions, and facilitate the functioning of lactate as a preferred energy 
metabolite to support axon function. Disruption of these transporters contributes to 
neurodegeneration [Jha and Morrison 2018]. 
 While there has to be a constant flow of energy to the neurons and glial cells, 
environmental energetic stressors lead to adaptive strengthening at the cellular and 
molecular levels [Camandola and Mattson 2017]. Physical exercise and food 
deprivation lead to synapse strengthening, formation of new synapses, and the 
production of new neurons from stem cells at the cellular level, and neuron resistance to 
a variety of stressors at the molecular level, bolstered via the activation of transcription 
factors that results in the expression of proteins. These changes add resistance to 
various neurodegenerative diseases. 
 
6. Concluding Summary 
Brain energetics are central to proper functioning at the cellular, subcellular and system-
wide scales. An understanding of the mechanisms of each scale, and how these couple, 
is critical to the comprehensive understanding necessary for the development of 
effective clinical interventions with minimal unintended consequences. 	  Mitochondria	  	  
1. Morphology and Function  
Mitochondria are intracellular organelles, with primary functions including the 
maintenance of energy homeostasis, cell integrity and survival [Simcox and Reeve 
2016]. Mitochondria comprise approximately 20% or more of cell volume, attesting to 
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their importance. In the aggregate they comprise approximately 10% of body weight. 
These organelles produce up to 95% of a eukaryotic cell’s energy (ATP) through 
oxidative phosphorylation [Tzameli 2012] driven by an electrochemical gradient created 
by the respiratory chain. They are double-membrane organelles with tightly packed 
cristae inside the inner membrane, resulting in a significant increase in surface area 
(much in the same way as the folded cerebral cortex) over which oxidative 
phosphorylation and maintenance of the proton gradient can occur. Cristae biogenesis, 
regulated through ATP synthase, which is also responsible for the majority of cellular 
energy production, closely links mitochondrial morphology to energy demand [Simcox 
and Reeve 2016]. The human body consumes on average a quantity of ATP per day 
that approximates its body weight [Zick and Reichert 2011].  
Mitochondria exist in varying numbers dependent on cell type and may form an 
intracellular network of interconnecting organelles, extending throughout the cytosol and 
in close contact with the nucleus, the endoplasmic reticulum, the Golgi network, and the 
cytoskeleton [Benard et al 2007]. The mitochondrial network is also known as the 
mitochondrial reticulum. The word reticulum is defined as a net-like formation or a 
network. “Mitochondrion,’’ when translated from the Greek means “thread grain.’’ 
Mitochondria may exist as small isolated particles, or as extended filaments, networks 
or clusters connected via intermitochondrial junctions. Single-section electron 
microscopic pictures of the cells only showed a two-dimensional image of the 
mitochondria, with the third dimension being lost. Serial-section images recovered that 
third dimension, showing filamentous mitochondria, frequently linked into networks 
[Skulachev 2001]. Extended mitochondria, and electrically coupled mitochondrial 
clusters, can serve as a system of effective power transmission in the form of 
membrane potential between remote parts of the cell. To avoid local damage due to a 
discharge of many of the organelles within the cell, the mitochondrial contacts by which 
networked mitochondria are coupled can be switched off (and on) as needed. 
Interestingly, isolated mitochondria unite into extended mitochondrial systems when the 
cell encounters energy shortages. (This reminds us of how astrocyte networks control 
the extent of their connections via gap junctions.) In tissues composed of large cells 
with high energy demands, extended mitochondrial systems occupy much of the cell 
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volume. Under certain physiological conditions and pathological conditions, such as a 
depletion of mtDNA, mitochondrial filaments and networks can decouple into single 
mitochondria. Extended mitochondrial systems exist only when their energy coupling 
and transmitting machineries are functioning normally [Skulachev 2001]. Muscle fibers 
require a specialized spatial organization of the mitochondrial network [Vinogradskaya 
et al 2014]. 
There is a coupling between mitochondrial morphology (network organization) 
and its bioenergetic function. Alternate configurations interact with bioenergetic 
properties in a way that is not fully understood, but the relationship is bidirectional 
[Benard et al 2007]. Wai and Langer [2016] connect mitochondria morphology to their 
functioning. In particular, how fusion and fission shape morphology, and that disruption 
of these, for example unopposed fission or fusion, adversely impact cellular and 
organismal metabolism, leading to potentially devastating dysfunction. Fusion and 
fission are also denoted as mitochondrial dynamics. 
Frequent cycles of fusion and fission [Pagliuso et al 2018] adapt the morphology 
of the mitochondrial compartment to the metabolic needs of the cell, and optimize the 
organelle’s bioenergetic capacity. Mitochondrial fusion optimizes function by spreading 
metabolites, enzymes, and mitochondrial gene products throughout the mitochondrial 
compartment, and counteracts the accumulation of mutations during aging. Extensive 
adaptations of mitochondria to bioenergetic conditions also occur at the level of the 
inner membrane ultrastructure and the remodeling of mitochondria cristae [Westermann 
2012]. 
Fused mitochondria permit optimal functioning in respiratory active cells due to 
the mixing of the matrix and the inner membrane, allowing close cooperation by the 
respiratory machinery. Fusion engages the entire mitochondrial compartment in 
respiration, maximizing ATP synthesis. A sudden need for metabolic energy may lead to 
the formation of hyperfused mitochondrial networks as a result of cell stress. 
Interestingly, such short-term stress exposure in starvation results in fusion that 
optimizes mitochondrial function. This also plays a beneficial role for the maintenance of 
bioenergetic capacity in the long term. In a complementary way, fission contributes to 
the maintenance of bioenergetic capacity by eliminating irreversibly damaged 
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mitochondria by autophagy  [Westermann 2012]. Furthermore, the activity of key 
proteins of mitochondrial dynamics is regulated at multiple levels, in direct response to 
the bioenergetic state of the mitochondria. Three members of the Dynamin family, which 
are GTPase enzymes, are key components of the fission and fusion machineries [van 
der Bliek et al 2013]. We still have a limited knowledge of the mitochondrial proteome, 
but expect it to be customized to location. 
Mitochondrial dysfunction is recognized as a key aspect of both acute and 
chronic allostatic states, that is, states of stress from which homeostasis is attempted. 
Genetic and environmental factors lend variability to mitochondrial stress response 
function [Manoli et al 2007]. 
It is clear that limited models of abnormal mitochondrial dynamics are insufficient 
to explain phenotypic variability in symptoms; information, and mechanisms need to 
function across multiple levels of organization [Eisner 2018]. Required are dynamic 
models of mechanisms at the molecular and organelle levels over long time periods. 
Purely descriptive representations cannot accurately picture multivariate dynamics. As 
suggested elsewhere in this paper, it appears that physiological and pathological 
processes result from biochemical, morphological and mechanical dynamics at more 
than one scale.  
The mitochondrial network changes its shape and distribution in the cell largely 
via the evolutionarily conserved activities of mitochondrial fission, fusion, motility, and 
tethering. The connectivity of the network is governed by the relative rates of 
mitochondrial fission and fusion, suggesting that the two processes are coordinated as 
a result of energetic needs. In complex polarized cells such as neurons, mitochondria 
must be actively transported and tethered to, and maintained, in active synaptic regions. 
Tethers are important for positioning mitochondria within the overall cell structure, and 
also relative to other organelles. There is evidence that the four conserved activities – 
fission, fusion, motility and tethering – are interdependent and that the dysfunction of 
one activity can have consequences on another. For example, attenuation of fission 
disrupts the transport of mitochondria to neuronal synapses, resulting in detrimental 
effects on cell function. Tethering defects can reduce fission rates. A full understanding, 
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therefore, requires an understanding of each process individually, and all processes as 
a coupled system [Lackner 2014]. 
The term mitochondrial plasticity is used to describe their adaptation to neuronal 
energy states via changes in morphology (form), function and position. Since the 
primary site of neuronal energy consumption is at the synapse (pre and post), it is there 
that mitochondria congregate and adapt to local energy needs via feedforward and 
feedback regulatory mechanisms [Rossi and Pekkurnaz 2019].  Furthermore, at the 
molecular level, mitochondria and axonal cytoskeleton tracks (such as actin filaments 
and microtubules) regulate mitochondrial distribution and dynamics. A motor-adaptor 
complex exists on the mitochondrial surface that contains kinesin and dynein. This 
complex contains the proteins Miro and Milton and is responsible for much, although not 
necessarily all, mitochondrial movement [Schwarz 2003]. Multiple signaling pathways 
converge on this complex to tailor mitochondrial positioning [Rossi and Pekkurnaz 
2019]. Perhaps via an optimization interpretation, choices are made among the multiple 
signals via an evolutionarily refined weighting mechanism, resulting in particular 
mitochondrial movement. Similarly, mitochondrial plasticity in response to immediate 
energy needs at synapses can also be interpreted to be an optimization of energy 
availability and use where it is most needed.  
We suggest that such “choices” are in some sense optimal and evolutionarily 
conserved to assure that energy supplied matches demands. Where this does not 
occur, due to insults to the system or to system defects, such as in mtDNA, the optimal 
choice becomes one where dysfunction occurs, resulting in pathologies and 
neurodegenerative diseases. While data can help create a framework for understanding 
how the distinct signaling pathways are correlated in space and time to assure 
mitochondrial bioenergetics and distribution throughout the synapse, mathematical 
models that represent the optimal choices can be powerful tools for a systematic 
understanding.  
There is substantial evidence that the mechanical aspects of cellular and 
mitochondrial dynamics, and organelle dynamics generally, are intimately coupled to 
numerous biochemical processes related to healthy cell functioning, and to pathological 
developments [Feng and Kornmann 2018]. For example, ion channels are 
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mechanosensitive, proteins can be curvature sensing, and the cytoskeleton and plasma 
membrane are force sensing. Organelles are dynamic and move around the cytoplasm, 
resulting in physical contact with each other, allowing them to exchange metabolites 
and information. This intermingling appears to be an important feature for the proper 
functioning of eukaryotic cells. It is hypothesized [Feng and Kornmann 2018] that 
biological phenomena observed at organelle contact locations are, at least, partially 
attributable to mechanical stimulation, for example, reticulum-induced mitochondrial 
fission. Mechanosensitive signaling pathways are critical components of a complete 
understanding of cellular and intracellular mechanisms [Moeendarbary and Harris 2014, 
Petridou et al 2017]. 
An understanding of the two-way coupling between the mechanical properties of 
cells and how physical loads on cells lead to biological and chemical responses is 
critical, in particular for the development of clinical diagnostics as well as therapeutically 
successful interventions. It is also known that many chemicals can alter the mechanical 
properties of living cells [Lim et al 2006]. As such, certain cellular mechanical properties 
can be utilized as indicators of health.  
Based on theoretical arguments [Hoitzing et al 2015] a number of hypotheses are 
suggested regarding mitochondrial networks and their dynamics: (i) selective mitophagy 
is not required for quality control because selective fusion is sufficient; (ii) increased 
connectivity may have nonlinear effects on the diffusion rates of proteins; and (iii) fused 
networks can act to dampen biochemical fluctuations, making them less susceptible to 
the effects of such fluctuations. The structure of mitochondrial networks is also modeled 
using network tools and percolation theory [Zamponi et al 2018], which is generally 
used to model the movement and filtering of fluids through porous materials. 
The mitochondria connect with the endoplasmic reticulum (ER) (both are tubular 
organelles) where proteins situated on opposing membrane faces may interact and 
tether the two organelles to each other. The ER-mitochondria interface provides a 
platform for the regulation of different processes: coordination of calcium transfer, the 
regulation of mitochondrial fission, the regulation of inflammasome formation, and the 
provision of membranes for autophagy. The ER regulates mitochondrial dynamics, and 
morphological changes, thus affecting cell health. The ER and mitochondria 
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communicate reciprocally, transmit danger signals that can trigger multiple, synergistic 
responses, including increasing the number of ER-mitochondrial contact sites to allow 
for enhanced molecular transfers [Giorgi et al 2009, Marchi et al 2014]. Given the 
criticality of proper mitochondrial function to good health, an understanding of the ER-
mitochondria interface is relevant to understanding human diseases that are believed to 
arise from mitochondrial dysfunction. 
In addition to the ER, mitochondria have bidirectional communications with other 
cellular organelles, in particular, lysosomes, and peroxisomes. This communication is 
involved in the pathology of mitochondrial diseases [Diogo et al 2018]. Genetic defects 
in mitochondrial proteins cause a large group of diseases known as mitochondrial 
diseases, discussed below. One result of these diseases is that lysosomes and 
peroxisomes are affected structurally and functionally. In the other direction: many 
lysosomal and peroxisomal diseases perturb mitochondria; lysosomal storage diseases 
perturb peroxisomal metabolism and mitochondrial function; peroxisomal diseases often 
lead to perturbations of mitochondrial structure, redox balance and metabolism; 
saturation of lysosomal capacity is often observed in mitochondrial diseases, with 
accumulation of dysfunctional lysosomes and autophagosomes. Clearly, a full 
understanding of cellular metabolism and mitochondrial diseases requires an 
understanding of how the mitochondria communicates with the rest of the cell. While 
some understanding can be gathered by a reductionist consideration of the 
mitochondria, this can only be considered as a first step. 
Mitochondrial motility, or trafficking, is critical for the survival of all cells, but likely 
more for neurons than all other cells, primarily due to exceptional neuronal morphology. 
Neurons extend their axons and dendrites distances of up to a meter, between two and 
three orders of magnitude greater than most other cells. The trafficking of mitochondria 
in neuronal axons, which lie flat and are typically about a micrometer in diameter, is 
along linear arrays of uniformly polarized microtubules, where the negative ends of the 
tubules are anchored in the cell body and the positive charge ends in the distal tips. 
Rather than forming a complex reticulum, in the axons mitochondria have separated 
from the reticulum and exist as discrete organelles of dimension typically 1-3 microns 
(micrometers), with those in dendrites tending to be longer. Mitochondria must provide 
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the energy required for the proper functioning of the neurons, especially at the 
synapses, where energy demand is greatest. The mitochondria must traffic to high 
energy demand sites as needed, where such demand is a dynamic process and can 
change rapidly. Interestingly, about 10%-40% of the mitochondria are moving at any 
instant of time, and of those about half are moving away from the cell body 
(anterograde, kinesin-dependent) and half toward the cell body (retrograde, dynein-
dependent). It is also speculated that the mechanism of movement and fusion are 
mechanistically coupled. A rich and complex regulatory machinery has evolved to 
manage the distribution of mitochondria over long distances and matching their 
distribution to a very dynamic demand for energy [Schwarz 2013].  
Molecular machinery underlies mitochondrial movement and dynamics (quality 
control via fusion and fission). Mitochondria must navigate the highly branched paths of 
the complex neuron geometry, and know where and when to stop. A diverse and 
sophisticated molecular system is used by neurons to transport and anchor 
mitochondria. Machinery for fission and fusion can intersect with machinery for motility. 
Similarly, molecular machinery controls mitochondrial quality, using feedforward and 
feedback mechanisms. If there is molecular misregulation of mitochondria, 
neurodegeneration is possible. Such mitochondrial dysfunction, in conjunction with 
other malfunctions, can result in pathological conditions, or can be the direct cause of 
neurodegeneration [Vanhauwaert et al 2019]. 
In addition to their role in ATP production via oxidative phosphorylation, 
mitochondrial functions include iron-sulfur cluster formation, calcium handling, apoptosis 
and quality control through fission and fusion, cell signaling, cell repair and 
maintenance, and ROS production [Simcox and Reeve 2016]. ROS emission is a 
dynamic balance between production and scavenging [Kembro et al 2013]. As part of 
their critical metabolic functions, mitochondria also perform critical apoptosis functions 
[Vakifahmetoglu-Norberg et al 2017]. Mitochondrial dysfunction can arise from a host of 
causes, from genetic defects to other intra- and extracellular environmental instigators, 
and are a nexus pathological feature for incurable neurodegeneration [Correia and 
Moreira 2018], leading to motor, behavioral and cognitive loss of function, leading to 
death. Neuronal fate is tied to successful coupling between mitochondrial bioenergetics 
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and dynamics (morphological changes, changes in transport and turnover). The 
importance of mitochondria in neuronal function is evidenced by their large numbers at 
synaptic locations.  
It is clear that the mitochondria are a fundamental component for healthy living. 
In particular, their optimal functioning and efficient energy usage are necessary to avoid 
numerous pathologies. Optimalities are maintained at all levels of functioning, for 
example, preserving an optimal pool of mitochondrial nicotinamide adenine dinucleotide 
(NAD) [Tzameli 2012]. The stages of metabolism have been evolutionarily optimized 
and have become efficient.  
The tight coupling between cellular bioenergetics, metabolism, the inner 
membrane structure, and mitochondrial function, as well as neuronal energy 
requirements at a high and continuous level, suggest that understanding these 
connections in a fundamental way is a link to understanding neurodegenerative 
diseases, bioenergetic dysfunction, and mitochondrial diseases, and hopefully to the 
identification and the enacting of clinical efforts for recovery.  
 
2. Mitochondrial Disease and Neurodegenerative Disorders 
Primary defects of mitochondrial function have been described for the five complexes of 
the respiratory chain, mtDNA replication and translation, respiratory chain cofactor 
synthesis, protein/solute import, and membrane structure and function. Secondary 
mitochondrial dysfunction relates to the impact of primary defects on diseases such as 
Alzheimer’s, Huntington’s, cancer, and in the aging process [Lemonde and Rahman 
2014]. Some of these are discussed subsequently. Mitochondria also appear to be 
involved in the pathogenesis of multiple sclerosis [Adiele and Adiele 2019].  
Mitochondrial dysfunction is initiated by glutamate excitotoxicity [Greenwood et al 
2007], which may be implicated in the secondary cascades of traumatic brain injury, as 
well as in neurodegenerative diseases of the central nervous system. 
Even relatively minor mitochondrial dysfunction leads to devastating systemic 
neurological and neurodegenerative disorders (APHALS), for example, Parkinson’s 
disease, and Huntington’s disease, which also has psychiatric components [Buhlman 
2016]. Mitochondrial bioenergetics and dysfunction can lead to a failing heart [Sheeran 
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and Pepe 2017]. ADP and Ca++ signals contribute to the matching of energy supply and 
demand during changes in heart workload, and oscillations of mitochondrial ATP 
regulate the cardiac action potential [Wei et al 2011]. While many mitochondrial 
disorders are multisystemic, some are very specific, for example, optic neuropathy, 
sensorineural deafness, and type 2 diabetes mellitus [Schapira 2012]. 
Mitochondrial disease can be described as a group of diseases characterized by 
even small misfiring of mitochondrial energy production, usually in the respiratory chain 
within the five enzymatic complexes, which are housed in the so-called matrix. This 
respiratory chain is controlled by the nuclear DNA, nDNA, and the mitochondrial DNA, 
mtDNA. Due to the nature of mitochondrial genetics, that each cell has hundreds or 
thousands of mtDNA copies, during cell division genetic mutations in mtDNA are 
distributed to the daughter cells randomly. Daughter cells may have both mutant and 
wild (non-mutant) type mtDNA copies. With time, and further cell divisions, the tendency 
is for an accumulation of mutant cells. When the ratio of mutant to wild type mtDNA 
copies grows beyond a certain threshold, clinical symptoms of disease can occur. But 
with mutation, the phenotype may change, and different patients may manifest their 
diseases at different stages in different ways. The threshold is not a fixed number, but is 
random within a range. This randomness is evidenced by heterogeneous manifestations 
of mitochondrial disease [Kurt and Topal 2013].  
Mitochondrial fission and fusion are processes by which the organelle maintains 
quality control. An imbalance between these, which are mediated by the action of 
GTPases, results in mitochondrial dysfunction [Panchal and Tiwari 2019]. Fusion is the 
means by which mitochondria exchange intermembrane and matrix contents, including 
mtDNA. It dilutes damaged mtDNA and lowers the threshold ratio between mutant and 
wild types. Fission provides a mechanism to isolate for elimination components that 
become damaged due to age or due to increased oxidative stress.  
Mitochondrial dysfunction and defective dynamics are proposed as a key 
mechanism in the early stages of AD, with the cause given as energy loss. In particular, 
there is a direct proportion between mitochondrial oxidative phosphorylation in the AD 
brain and respective clinical disability. Such metabolic dysfunction correlates with 
abnormal mitochondrial morphology and fragmentation, and altered expression of 
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mitochondrial fusion and fission proteins. In ALS, impaired mitochondrial transport in 
axons is observed, as well as fusion and fission abnormalities. HD is also connected to 
abnormal mitochondrial morphology. In PD, there is excessive fission, resulting in 
mitochondrial fragmentation. In these big four neurodegenerative diseases, abnormal 
morphology is linked with genetic and toxin causes. In connection with this, reactive 
astrocytosis and microglial activation play a role in inflammation, in part due to 
mitochondrial dysfunction. Common phenotypes are mitochondrial structural and 
functional defects [Joshi and Mochly-Rosen 2018]. In genetic forms of PD, disruptions in 
synaptic vesicle endocytosis (SVE) significantly contribute to disease pathogenesis. 
Mitochondria provide ATP to power SVE, which replenishes synaptic vesicles to sustain 
repeated release of neurotransmitters. Mitochondrial and lysosomal dysfunction have 
been found to be key cellular processes that contribute to PD pathogenesis in such 
genetic forms of PD [Nguyen et al 2019]. 
It is interesting to note and observe that mitochondrial dysfunction can be a 
cause of age-related neurodegenerative diseases, but can also be implicated in the 
progress of such diseases, their pathogenesis. It is important to recognize that there are 
numerous progression paths and possible initiations of neurodegenerative diseases, 
and mitochondrial dysfunction can be an initiator or a contributor, or both in the case 
where the disease initiates feedback loops to the mitochondria, creating a spiral of 
degeneration. Mitochondrial dysfunction can precede or occur concurrently with an 
onset of pathologies. 
Aging can lead to an accumulation of reactive oxygen species (ROS), which are 
major contributors to oxidative stress, due to the imbalance between the production of 
ROS and their oxidation, which then affects mitochondrial respiratory chain function.  
Membrane permeability is altered as is calcium homeostasis, increasing heteroplasmic 
mtDNA and weakening mitochondrial defense systems. It is generally agreed that 
mtDNA mutation, oxidative damage (which can be minimized via exercise and caloric 
restriction), and/or aggregation of mitochondrial proteins leading to abnormal 
mitochondrial morphology are the main reasons for the organelle’s dysfunction. 
Cumulative oxidative stress is viewed as the critical factor that precedes a cascade to 
dysfunction [Elfawy and Das 2019]. 
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There is evidence that mitochondrial dysfunction is linked to Rett Syndrome, and 
Autism Spectrum Disorders (ASD). In the latter case, links between abnormalities in 
mtDNA and the pathogenesis of ASD, which is a dynamic system of metabolic and 
immune anomalies involving many organ systems, including the brain, have diverse 
clinical manifestations and many genetic and environmental factors implicated in its 
development [Castora 2019]. Mitochondrial dysfunction may be present in up to 80% of 
children with ASD. Given the central role of mitochondria in energetics and the immune 
system, the high correlation between ASD and mitochondrial dysfunction is 
understandable. Additionally, one quarter of patients with mitochondrial disease 
experience epilepsy. There is strong evidence that metabolic change and mitochondrial 
dysfunction could be an important pathogenic process in epileptogenesis [Chan et al 
2019]. These can be due to respiratory chain deficiency in both astrocytes and 
interneurons. 
Due to the pleiotropic nature of nearly all mediators involved in mitochondrial 
function, quality control and cell death execution, interventions that target a single 
protein can have unexpected large-scale effects in multiple pathways, challenging those 
planning interventions [Sedlackova and Korolchuk 2019]. 
Mitochondrial dysfunction and disease are at the core of the initiation and 
progression of the major neurodegenerative and neuropsychiatric diseases. A key to 
understanding the disease pathology requires quantitative models of energetics at more 
than one scale, something that is currently lacking. 
Mitochondrial diseases have a major relevance to military health. Approximately 
one third of the 1990-1991 Gulf War veterans – in the range of 175,000-250,000 
soldiers – developed chronic multisymptom health problems with mechanisms that 
adversely affect mitochondria. Symptoms include muscle and brain fatigue with variable 
additional domains affected. Such chronic and long-lasting (to this day) multisymptom 
health problems are known by the term “Gulf War Illness” (GWI). In addition to the 
above, there are elevated instances of cognitive difficulties, muscle pain and weakness, 
shortness of breath, gastrointestinal problems, sleep problems, and behavioral changes 
[Koslik et al 2014]. 
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 Environmental factors are clearly implicated in GWI. Exposures to excessive and 
unique environments, as well as combinations of toxic exposures, particularly 
acetylcholinesterase inhibitor (AChEi), have led to toxic and lethal results via ROS and 
mitochondrial dysfunction (MD). These two outcomes are tightly coupled due to the fact 
that mitochondria are both target and source of ROS. It has been shown [Koslik et al 
2014] that the post-exercise phosphocreatine-recovery time constant (PCr-R), a marker 
that serves as an estimate of net oxidative ATP synthesis, is a robust index of MD. A 
comparison of this index for GW veterans (GWV) to a control group shows that values 
of PCr-R for veterans can be more than twice those of the control group. Elevated rates 
of amyotrophic lateral sclerosis (also linked with MD) are also observed in GWV. 
 Elevated levels of mtDNA content and damage in circulation are markers for MD 
[Chen et al 2017]. Symptoms in GWV to control groups are reported in the following 
approximate ratios: fatigue 4/1; pain 21/1; neurological/cognitive mood 5/1; skin 
symptoms 2/0; gastrointestinal 4/0; respiratory 2/0. It was found that mtDNA damage in 
GWV is 20% greater than in the control group. Levels of nuclear DNA lesions were also 
elevated in GWI. All these results taken together are interpreted as evidence that 
mitochondrial dysfunction is involved in the pathobiology of GWI, and helps explain the 
persistence of the illness over 25 years, but not universally, as certain mitochondrial 
haplogroups are known to offer protection for specific neurodegenerative diseases 
[Chen et al 2017]. 
   
3. Modeling 
Given the significance of mitochondrial function and dysfunction, there have been a 
small number of works on the mathematical modeling of various aspects of their 
functions [Magnus and Keizer 1997, 1998a,b]. These models can be quite complex, 
with simpler derivative models attempted [Bertram et al 2006, Saa and Siqueira 2013]. 
These quantitative models governed ATP production during glucose metabolism via 
oxidative phosphorylation. The ability to connect mitochondrial dynamics mathematically 
to neuronal spike generation can be a powerful tool in disease modeling and enable 
clinical interventions that are not yet possible otherwise [Venkateswaran et al 2012]. 
The challenge is to populate the equation parameters, currently not fully possible. 
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 The goal of computational models is to provide a general mathematical 
framework for the description of physiological system behavior under broad conditions. 
For example, an understanding of cellular function and dysfunction relies on a 
quantitative description of mitochondrial function and dysfunction. The larger framework 
requires computational models that span multiple scales: molecular, cellular, tissue, and 
whole-organ self-consistent models that naturally integrate across disparate scales. 
These mathematical models must satisfy the laws of chemical (bio)physics, of course, 
rather than be just products of data fitting. While data-driven models can accurately 
represent a narrow slice of reality, they do not accurately extrapolate beyond the 
originating data, and do not integrate across scales, much less provide a first-principles 
understanding. Data-driven models at different scales do not match at their boundaries. 
A computational model that meets the above attributes [Beard 2005] for the 
mitochondrial respiratory chain is derived to appropriately balance mass, charge, and 
free energy transduction. The components of this validated model are: the reactions at 
complexes I, III, and IV of the electron transport system, ATP synthesis at F1F0 ATPase, 
substrate transporters including adenine nucleotide translocase and the phosphate-
hydrogen co-transporter, and cation fluxes across the inner membrane including fluxes 
through the K+/H+ antiporter and passive H+ and K+ permeation.  
 
4. Concluding Summary 
Given the central role played by mitochondria in cellular energetics, and that 
mitochondria are involved in almost all neurological disorders, to understand how 
mitochondria function is at the core of understanding neurological health, and also 
understand how dysfunction results in many of the most debilitating and fatal 
neurodegenerative diseases. This understanding can lead to therapeutic interventions 
to improve the health of many millions of people who suffer from these diseases.  
 The focus of our research efforts is an understanding of how and why 
mitochondria move, stop and anchor, undergo fusion or fission, degrade on the spatial 
and temporal scales needed to meet the broad spectrum of energy needs, as well as 
Ca++ buffering needs, throughout the neuron. Such complexity suggests the existence 
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of energy-based mechanisms that operate locally (sub-optimizations) and globally 
across multiple cells and beyond (full optimizations). 
 Traumatic	  Brain	  Injury	  	  
1. Introduction 
Numerous and significant advances have been made to our understanding of the 
human brain, how it functions on multiple scales, and how its various processes function 
biochemically and biophysically. While numerous challenges exist, real progress has 
been made, especially in the past several decades. One important clinical goal is the 
translation of this newfound knowledge and understanding to traumatic brain injury (TBI) 
rehabilitation.  
        Just as the brain operates on numerous scales, TBI, from initiation to reactions, is 
a multiscale event that evolves over timescales from the order of the initiating insult (µs) 
to days-weeks-months-years. TBI is complex and heterogeneous, with dynamics that 
are very sensitive to the initial conditions (location and morphological variations, insult 
object velocities and accelerations) and the health and genetic predispositions of the 
injured person. In the field of nonlinear dynamics, such sensitivities result in a spectrum 
of possible dynamics, with some paths leading to instabilities, and others to equilibria or 
homeostasis. Sometimes, we are more interested in the stability characteristics of the 
ensemble of TBI system dynamics rather than the particular trajectory since ensemble 
results allow us to determine the range of system parameter values that assure stability, 
or instability. Other times we seek a sample TBI response from the ensemble in order to 
observe a time history, perhaps to assess a particular clinical intervention. 
       In the next section, we discuss glial cells, in particular astrocytes and NG2-glia, due 
to their fundamental importance to TBI response. While other glial cells are also 
fundamental to this response, we focus on astrocytes and NG2-glia in order to suggest 
a possible approach to the modeling, which can be extended to other glia, such as 
oligodendrocytes and radial glia.  
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       To understand TBI, we need to understand the fundamental aspects of the interplay 
and coupling between astrocytes and the synapses during normal functioning, and the 
biochemical processes that are initiated by microglia that drive astrocytes into a 
neurotoxic state. In a similar way, the dynamics of pre-TBI NG2-glia and their evolution 
post TBI can suggest clinical interventions. We note that the various glial subtypes 
behave differently prior to injury and post injury. For example, astrocytes react and 
function differently at early stages after injury than at later stages, in fundamental ways, 
with significant implications for the design of therapeutic measures as well as for the 
patients. 
       The dynamic map that is being created by researchers of glial types and functions 
is not only time-dependent, but also heterogeneous, and, with regard to TBI, these 
functions are sensitive to the characteristics of the originating insult and its location. 
Following TBI, astrocytes undergo a diverse and context-specific set of rapid changes in 
gene expression, morphology and function, collectively referred to as astrocyte 
reactivity [Dimou and Gallo 2015, Gotz et al 2015, Burda and Sofroniew 2017]. There 
exist a molecularly diverse set of subtypes of astrocytes that may serve a multitude of 
beneficial or deleterious roles. A key focus for TBI research is to understand the key 
molecular and cellular mechanisms driving such responses, and the functional 
implications of different forms of astrocyte reactivity [Burda and Sofroniew 2017]. 
 
2. Background and Significance 
Traumatic Brain Injury (TBI) is a major cause of disability and death worldwide.  
Accidents and traumas acquired in war result in devastating injuries that, even if 
survived, result in severely limited lives of the injured as well as their supportive 
families.  Various TBI classifications exist, the commonly used Glasgow Coma Index, or 
by use of pathological features. TBI damage may be classified to be focal or diffuse, the 
latter sometimes manifesting little obvious initial damage without the use of 
sophisticated imaging techniques, but potentially deadly even over relatively long time 
scales. 
TBI includes concussion, contusion (including coup contrecoup), diffuse axonal 
injury (DAI), traumatic subarachnoid hemorrhage, and hematoma [Al-Sarraj 2016]. It is 
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common that TBI results in more than one of these types of injuries. Secondary injuries 
occur as a result of the body’s inflammatory response to the primary injury. This 
inflammation within the rigid skull of fixed volume results in an increase in pressure 
within the head. How to delineate and define TBI has been fundamental for research 
advances, allowing groups to compare and interpret results on an identical basis of 
understanding [Menon et al 2010]. As we discuss below, other secondary effects occur 
as part of a complex sequence of biochemical reactions that are not yet fully 
understood. 
Widespread axonal damage, known as diffuse axonal injury (DAI), not 
necessarily immediately debilitating or fatal, can trigger secondary cellular processes 
and biochemical reactions that create unstable inflammation, resulting in greater 
damage than was caused by the primary injury. DAI is a shearing and stretching of 
nerve cells due to a rapid acceleration/deceleration motion of the brain. DAI is the most 
prevalent pathology of coup contrecoup. There is evidence that a single TBI can be a 
cause of later onset of neurodegenerative disorders such as Alzheimer’s disease.  
Additional pathways to clinical dysfunction appear to exist, even from morphologically 
intact axons with disrupted physiology. An understanding of these pathways provides 
important therapeutic targets in the treatment of TBI, with mitigation of 
neurodegeneration [Johnson et al 2013, Rishal and Fainzilber 2014]. 
  Substantial efforts have been made to understand the mechanical aspects of 
impact and how such forces translate into the brain at large and small dimensional 
scales [Hardy et al 1994, Hemphill et al 2015, LaPlaca et al 2007]. Advanced 
constitutive models are used with the goal of relating mechanical damage to 
physiological brain dysfunction [El Sayed et al 2008]. 
A significant challenge is to ascertain the mechanical properties of the brain, at 
all these scales, upon which the biomechanical models are based [Chatelin et al 2010, 
Jin et al 2013, de Rooij and Kuhl 2016, Zhao et al 2018].  
TBI mortality rates range from 20% to 50%, depending on the initiating trauma, and 
these percentages have been declining recently, especially in wealthier societies where 
the emergency infrastructures are more advanced.  In the US alone there are an 
estimated 2.1 million TBI cases per year, causing about 100,000 deaths per year and 
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500,000 hospitalizations [Büki and Povlishock 2006]. A broad spectrum of initiation and 
response mechanisms exist for TBI, but due to the hidden nature of some of these 
injuries, and the variety of individual reactions, treatment decisions challenge those at 
the front lines [Peebles and Cruz 2018]. Yet there are fundamental neurochemical and 
metabolic responses to TBI that suggest therapeutic approaches for early intervention 
[Prins et al 2013]. Using lactate as a fuel after TBI has been proposed, but the 
astrocyte-neuron lactate shuttle, which is at least controversial to some and opposed by 
others, needs to be carefully evaluated before being utilized in patient care [Dienel 
2014]. This debate on the shuttle has been discussed earlier in this paper. 
TBI has been viewed as primarily a male problem, due to the involvement of 
more men in activities that increase the risk of TBI, and resulting in using male animals 
for preclinical research. However, this view has evolved as the population ages and 
females are more involved in activities that can lead to TBI. Thus, preclinical efforts are 
beginning to account for sex-related responses [Spani et al 2018]. 
 While initial diagnosis is challenging, and early treatment – within about an hour 
– is critical, there are treatments for the deteriorating pathological stages encountered. 
Medications for secondary injuries are still in the research stage, and least understood. 
This is true even though there have been tremendous advances in understanding 
neuro-glia systems, their biochemical couplings, and the genetic foundations of how the 
brain both recovers and deteriorates after TBI. 
The primary approaches to understanding the biomechanics of TBI, as well as 
the pathophysiology of TBI, require in vivo and in vitro experiments, tests, and 
examinations of those who have succumbed to their injuries. The brain responds to TBI 
with complex, interdependent processes, with multidimensional dynamics, in a 
cascading way [Prins et al 2003, Bernick et al 2011].  
Animal models have provided the community with the overwhelming majority of data 
and subsequent understanding, translating that understanding clinically [Laurer et al 
2000]. A smaller component of our understanding is derived from theoretical 
(mathematical) and computational models. Often there are not enough data to populate 
the theoretical models. But the derivations of such models open up the field to broad 
development, suggesting new avenues of research via in silico experiments. 
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3. Cellular Level Behavior 
Given the widespread and devastating aspects of diffuse axonal injury, we focus here 
on DAI, how glial cells respond, in particular the dynamics of astrocytic and NG2-glia 
behavior and response post TBI and over long time scales. A recent symposium broadly 
focused on glia-neuron interactions [Glia-Neuron 2018]. 
Here we discuss damage and response at the neuronal and glial level. An 
understanding at this scale requires attention beyond the neuron, especially for the 
development of rehabilitation and regeneration treatments to be applied at this 
biochemical scale. 
The secondary effects discussed above can progress for years after TBI. One 
subgroup of TBI, DAI, results in traumatic axonal injury (TAI), a major driver of mortality 
and functional impairment [Hill et al 2016].  DAI pathology includes secondary 
physiological damage, for example, twisting and misalignment of axon microtubules and 
separation, resulting in loss of axonal transport [Kallakuri et al 2012], progressive 
swelling and degeneration. Secondary injuries result from biochemical cascades that 
occur in response to primary injuries. Axonal primary mechanical damage leads to intra-
axonal calcium influx, resulting in destruction of the cytoskeleton, disrupting axoplasmic 
transport, and ischemia [Blumbergs 1998].  The Ca++ influx activates cysteine 
proteases, calpain and caspase, which play a pivotal role in cytoskeleton destruction. 
This pathological progression also initiates mitochondrial injury, resulting in the release 
of cytochrome-c. The resulting degradation of the axonal cytoskeleton causes local 
axonal failure and disconnection [Büki and Povlishock 2006]. Ca++ accumulation also 
produces reactive oxygen species (ROS), which are implicated in the pathology of TBI 
through the oxidative stress mechanism, and can also promote inner mitochondrial 
membrane permeability that forces the rupture of the outer membrane and the release 
of cytochrome-c that results in cell death through a chain of events [Gupta and Sen 
2016]. Pathological progression to a particular end is not unique. 
Variations in post-traumatic cellular bioenergetics and mitochondrial function may 
trigger or accelerate these damaging secondary intracellular cascades that follow the 
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primary injury, resulting in delayed secondary manifestations of injury and inflammatory 
responses [Watson et al 2014]. 
This coupling between TBI and metabolic dysfunction due to mitochondrial 
damage can result in quick cell death due to energy failure. Diet (omega-3 fatty acids) 
can modulate the interaction between mitochondrial homeostasis and synaptic plasticity 
as a mechanism that can regulate the capacity of the brain to resist TBI [Agrawal et al 
2014]. A better understanding of TBI from the clinical perspective for therapeutic 
strategies clearly requires an understanding of mitochondrial functioning and coupling 
with the metabolic aspects of neuronal and glial functioning. 
TBI-induced cellular-event cascades include potassium efflux, Ca++ 
accumulation, glutamate release, and increased oxidative stress that contribute to 
reduced ATP production with an increase in cerebral metabolic rates for glucose that 
can last for days and is a function of TBI severity. Reduced ATP production in 
conjunction with secondary insults result in secondary cellular damage. Increased 
energy demand, or a reduction in the availability of glucose after TBI, eventually 
reduces the functioning and survivability of neurons [Bartnik-Olson 2012]. As might be 
expected then, mitochondrial dysfunction appears to play a key role in the 
pathophysiology of TBI, in particular in reductions in mitochondrial state 3 respiratory 
rates (ADP-stimulated respiration) due to an uncoupling of the mitochondrial electron 
transport chain and mitochondrial permeability transition. The resultant energy loss 
contributes to cell death. 
An additional theory proposes that DAI is triggered by myelin debris from injured 
axons that cause inflammation as well as expression of cytokines, resulting in a 
cascading DAI [Yang et al 2011]. 
An understanding of how axons elongate in response to forces is needed in order 
to develop neurological treatment strategies. Under normal conditions, such forces 
result in normal axonal growth, known as passive stretching or towed growth. 
Mechanical signaling occurs and neurons respond by increasing protein synthesis and 
transport [Suter and Miller 2011]. This is still not fully understood. It has been suggested 
that neurofilament proteins, key structural cytoskeletal elements, may be important 
contributors to axonal tensile strength, and thus, to how axons respond to TBI. Insights 
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on these can contribute to the development of therapeutic strategies, hopefully to 
reverse neuronal degeneration following TBI [Siedler et al 2014]. 
Clinical challenges in drug trials to ameliorate TBI (DAI/TAI) are likely due to 
findings that a spectrum of cellular injuries occurs, at different locations, involving 
different receptors and biochemical pathways. Mathematical models that are linear, 
homogeneous and isotropic will not represent the brain accurately. There are critical 
factors that differentiate impact types, directions, and head movements. Characteristics 
of acceleration/deceleration, longitudinal forces coupled with shear strain forces 
resulting from rotational accelerations/decelerations, result in head/brain motions that 
lead to inelastic and permanent damage and ruptures.  
The secondary biochemical cascade of events can result in death to cells that 
have survived the primary injury, partly due to calcium influx into the cell. The 
therapeutic window may last from hours to days after injury, but this is vague and 
unknown in advance [Meythaler et al 2001], and is highly patient/circumstance 
dependent [Corbo and Tripathi 2004, Maurya et al 2006]. Diagnostic tools are critical to 
establishing the extent and nature of the damage, thus offering opportunities for 
interventions [Li and Feng 2009, Mohammadipour and Alemi 2017]. Biomarkers of 
axonal injury provide valuable guideposts for early detection of injuries that routine 
neuroimaging cannot detect [Manivannan et al 2018]. 
Axonal injury directly affects dendritic morphology, a critical byproduct of TAI, 
and such changes in dendritic structure may be the cause of cognitive decline after TBI. 
How TAI affects changes in dendritic structure is less understood. It has been observed 
that TAI alters dendrite morphology by causing periodic swelling, called dendritic 
beading, resulting in, it is believed, a disruption in ionic homeostasis. But given the link 
between such structures and cognition, an understanding is required for the design of 
clinical solutions [Monnerie et al 2010]. The formation of dendritic beads is also 
correlated to changes in mitochondrial morphology and function, with the majority of 
beads containing a dysfunctional mitochondrion [Greenwood et al 2007]. Alzheimer’s 
disease is associated with dendritic beads. 
Connections between TBI and Alzheimer’s disease (AD) are made at the 
cerebrovascular level. It has been suggested that cerebrovascular pathology, which is a 
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key element in both conditions, could indicate a mechanistic link between Aβ/tau 
deposition after TBI and the development of dementia and chronic traumatic 
encephalopathy [Ramos-Cejudo et al 2018].  Mitochondrial disease and dysfunction, 
already discussed, is linked to AD, both as a cause as well as an outcome of the 
disease.  Further investigation of the connection between TBI and mitochondrial 
dysfunction at the vascular level, especially regarding Aβ/tau deposits typically found 
near degenerating vessels, is warranted. 
While there are multiple scales of damage to the brain in response to 
biomechanical insult, it is at the cellular level that the damage occurs and the brain 
responds, and the loss and biochemical rehabilitation takes place. Axonal loss results in 
progressive neurodegeneration, and novel therapies have made minimal and 
inconclusive impact on clinical outcomes. More recent research outcomes resulting in a 
deeper understanding of the cellular and molecular mechanisms that are initiated due to 
injury hold the promise that such understanding can translate to therapies at that scale. 
We will discuss how glia, in particular astrocytes and NG2-glia, appear to play 
significant roles in complex and not fully understood ways in such mechanisms and 
therapies. 
Multiscale modeling approaches to predicting axonal strains resulting from TBI 
continue to make progress. Finite element methods, however, are challenged when 
scales range from organ (10-20 cm) to tissue (1 cm) to bundle (100-300 µm) to axon (1-
10 µm) [Wright and Ramesh 2012]. One benefit of multiscale models is that axonal 
strain can be used as a measure of TBI. Such a coupling between the cellular 
mechanisms of damage and the mechanical loading at the macroscale is needed. One 
significant conclusion from multiscale computations is that tissue strains do not scale 
with maximum axonal strain in general. This is due to axonal heterogeneities in 
orientation, stiffness property gradients between the axons and the local surrounding 
medium, and the anisotropic properties of the axons [Cloots et al 2013].  
 
4. Glial Cells  
“Virtually every aspect of brain development and function involves a neuron-glial 
partnership [Barres 2003].” Glial cells (astrocytes) perform transmitter cleanup 
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functions, maintain extracellular ion levels, and perform active control functions on 
synaptogenesis, synapse number, function, and plasticity. They (oligodendrocytes and 
Schwann cells) provide neuronal insulation and trophic support, control axon diameter, 
and the clustering of ion channels. Schwann cells also control regeneration of axons 
and the function of synapses at the neuromuscular junction [Barres 2003, Chung and 
Allen 2015]. Radial cells generate neurons and later glial cells, and participate and 
initiate a host of critical expressions. NG2-glia are observed to react very fast with a 
very large increase in proliferation (100-fold baseline in 1-3 days) at injury sites [Dimou 
and Gotz 2014], with still unclear outcomes and impact. As a part of this partnership 
between neurons and glia, there is evidence that neurons provide trophic support for 
glia. 
Glial cells, or neuroglia, maintain homeostasis, form myelin, and provide 
protection and support for neurons in the central nervous system. One glial function 
related to TBI is the destruction of pathogens and removal of dead neurons. On 
average, glial cells make up about fifty percent of the cells in the human brain. Some 
differentiated glial cells have reactivated stem and progenitor properties after insult. An 
understanding of which subtypes offer potential positive roles in repair can impact 
clinical response to TBI [Dimou and Gotz 2014]. 
Microglia, which comprise approximately 10-15% of all cells found in the brain, 
are the resident macrophage cells. They play a dual and critical role in the brain 
following TBI, initially promoting beneficial neurorestorative processes, but also 
producing inflammatory and cytotoxic mediators that hinder repair and cause cell death. 
An understanding of the mechanisms that control microglial shifts can suggest 
therapeutic strategies for TBI [Loane and Kumar 2016]. 
One response to damage to the central nervous system is gliosis, a hypertrophy 
of glial cells, resulting in a complex and not well-understood series of biochemical 
cascades, initially for the repair and containment of the damage, and then for 
remyelination and regeneration of axons and dendrites. As part of this sequence of 
events, an abnormal increase of astrocytes, called astrogliosis, occurs with a change in 
astrocyte morphology and molecular expression, resulting in a scar, and sometimes 
inhibition of axon regeneration. There is still debate regarding the scar and its role in 
	   38	  
TBI recovery, as well as regarding the time-dependent functions of the glia. (For 
example, while a scar does not form in wounded zebra fish, there is extensive 
regeneration of wounds.) Do the glia respond to damage and disease or do they make 
things worse, or both? The glia have a wide spectrum of functions, with cell-to-cell 
communications critical to the normal and efficient operations of the central nervous 
system. And yet, glial biology is not well understood. 
Neuron-glia communications govern the formation of synapses and plasticity, 
while a breakdown in communications between the cells may be a significant cause of 
neural pathologies and common degenerative disorders [Shaham 2005, Stogsdill and 
Eroglu 2017]. Neuronal connections during development are often inappropriate, 
excessive or transient, requiring axonal pruning by glia, sometimes in a survival of the 
fittest competition. Experience-dependent synapse elimination, as a result of activity-
dependent mechanisms, is critical for proper functioning, but the cellular and molecular 
mechanisms are only beginning to be understood [Corty and Freeman 2013, Allen and 
Eroglu 2017]. 
How individual glial cells respond to traumatic events is still under debate and 
study. From a morphological (structural) perspective, data is lacking since most 
research has focused on their electrophysiological and biochemical properties, and yet 
in order to understand and model brain reaction and response to traumatic injury, such 
properties are needed. Glial cells are softer than their neighboring neurons, and both 
types of cells are very soft, like rubber elastic [Lu et al 2006]. Glial cells can neither 
serve as structural support cells nor as glue, as originally thought. 
Astroglia perform many functions, including biochemical support of the blood-
brain barrier, maintenance of extracellular ion balance, and in response to traumatic 
injuries, with repair and scarring processes. There are several forms of astrocytes, 
located heterogeneously, each specialized to particular functions during specific times. 
They are active at synapses, secreting and absorbing neural transmitters, denoted as 
the tripartite synapse, referring to the pre and post synapse along with the astrocyte. 
Astrocytes are critical in health and disease/damage [Clarke and Barres 2013, Liddelow 
and Barres 2015, Verkhratsky and Nedergaard 2017].  
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 Astrogliosis is a spectrum of reactions that are context-dependent, and can result 
in a continuum of progressive changes in gene expression and cellular changes. It is 
complex and heterogeneous. Reactive astrogliosis and glial scar formation appear to 
have important roles in determining clinical outcomes to central nervous system trauma. 
There is evidence that reactive astrogliosis with scar formation can inhibit axonal 
generation after such trauma, as well as exert essential neuroprotective functions 
[Sofroniew and Vinters 2010]. The existence of molecularly diverse subtypes of reactive 
astrocytes that serve a multitude of beneficial or deleterious roles confirms that this is a 
central question in the study of neurobiology of disease and injury [Burda and Sofroniew 
2017]. TBI mechanopathogenesis is a trigger for astrocyte reactivity. This is how 
mechanical forces are translated into cellular dysfunction and damage. Understanding 
how this happens is fundamental to the development of therapeutic strategies for TBI, in 
particular, for milder forms of TBI that may cause widespread diffuse tissue damage but 
with little or no severe focal tissue damage [Burda et al 2016].  
In response to sensing changes in neural activity and extracellular space 
composition, astrocytes exert homeostatic mechanisms critical for maintaining neural 
circuit function, such as buffering neurotransmitters, modulating extracellular osmolarity, 
and calibrating neurovascular coupling. In addition to upholding normal brain activities, 
astrocytes respond to diverse forms of brain injury with heterogeneous and progressive 
changes of gene expression, morphology, proliferative capacity and function that are 
collectively referred to as reactive astrogliosis. Destructive mechanical forces cause 
tissue damage in traumatic brain injury setting in motion complex events that disrupt 
central nervous system (CNS) homeostasis. This disruption triggers diverse multi-
cellular responses that evolve over time and can lead either to neural repair or 
secondary cellular injury, depending on the severity of the insult. In response to TBI, 
astrocytes in different cellular microenvironments tune their reactivity to varying degrees 
of axonal injury, vascular disruption, ischemia and inflammation [Gotz et al 2015, Burda 
et al 2016].  
More recently studied in depth, NG2-glia are widely dispersed throughout the 
adult brain and CNS, but the full spectrum of their function is still generally not known, 
but remyelination after injury appears to be one function. NG2-glia respond to injury and 
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pathological conditions by transformations in cell morphology and proliferation rates. 
The specifics are sensitive to the nature of the insult and the age of the injured. The 
response is very fast, sometimes within one day, is highly dynamic, and the cells 
migrate toward the injury site. By the end of 28 days their numbers have decreased to 
their original density. Some hypothesize that the NG2-glia are responsible for wound 
closure and scar formation, to which axonal growth inhibition has been attributed. 
Positive and negative NG2-glia responses to pathological insults result in numerous 
explanatory hypotheses that may suggest new therapeutic strategies [Dimou and Gallo 
2015].  
There are selective signaling in the glia, in heterogeneous ways, very specific to 
insult type and location. The regulation of selective signaling might suggest 
opportunities for innovative therapeutic approaches to TBI [Dimou and Gotz 2014], in 
particular if an understanding can be developed regarding which glial subtypes create 
an adverse environment for the survival of new neurons, and thereby be potentially 
controllable.  
 
5. Theoretical Modeling 
Variational methods have been used for the derivation of theoretical neuronal or brain 
function models: nervous excitation [Dickel 1989], ionic solutions with applications to 
enzymes, ion channels and catalysis [Eisenberg 2011], energy coding the neural 
physical circuit [Chuankui 2012], and an electromechanical model of neuronal dynamics 
[Drapaca 2015].  
Even though the human brain comprises about 2% of the body’s mass, it 
requires about 20% of the body’s oxygen and glucose to make the ATP it needs. The 
biochemical reactions and processes are governed by equations that dynamically 
balance various forms of energy. Of course, the laws of physics are satisfied at all 
scales and in all forms. Astrocytes play a major role by capturing nutrient molecules 
from the blood stream and converting them into the energy required by the neural 
synapses, and, uniquely, also storing the glucose from the blood stream in the form of 
glycogen. Other energy exchanges occur between neurons and astrocytes, for 
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example, the retrieval of the neurotransmitter glutamate from neuronal synapses by 
astrocytes, a process that is energy expensive.  
An understanding of astrocyte energy metabolism enhances our ability to model 
astrocyte-neuron interactions, including energy exchanges, as part of the glial 
processes that are critical to neuronal functioning [Hertz et al 2007, Prebil et al 2011]. 
NG2-glia react rapidly to any type of injury with strong potential to repopulate areas of 
lesion. That NG2-glia are found in the healthy as well as pathological human brain 
suggests a possible role for the development of strategies to promote myelin repair. The 
identification of factors that control their proliferation and differentiation may suggest 
why the adult central nervous system fails to remyelinate after TBI. Endogenous NG2-
glia, therefore, represent a viable and effective target to regenerate oligodendrocytes 
and neurons [Dimou and Gallo 2015].  
Normal functioning of astrocytes and NG2-glia are altered by TBI, as discussed. 
The possibility of deriving a set of equations that govern these energy exchanges, 
interactions, and storage during normal functioning, and then post-TBI can be very 
valuable to our understanding, and open clinical options for healing and regeneration. 
Of particular value for clinicians is the possibility of testing specific treatments as inputs 
to the theoretical models, and studying the models’ estimates of clinical results.  
Of interest are reduced order models of astrocytes as they react to insult, that is, 
astrogliosis [Kimelberg and Nedergaard 2010, Dimou and Gotz 2014, Burda et al 2016] 
as well as NG2-glia phenotype changes [Dimou and Gallo 2015].  As we have 
discussed, astrogliosis is both complex and heterogeneous, with emerging evidence 
that different forms of astrocytes function via different mechanisms post-injury in the 
following ways: (i) regulation of inflammation, (ii) isolation of lesions and protection of 
adjacent neural tissue, (iii) regulation of the blood-brain barrier, and (iv) synaptic 
plasticity and neural circuit reorganization [Burda et al 2016]. From Burda et al:  
“Astrocytes sense and respond to mechanical strain after TBI. Physical strain 
deforms flexible networks of intermediate filaments within astrocytes and activates ion 
influx through mechanosensitive cation channels. Rises in intracellular calcium causes 
astrocyte ATP release that signals in an autocrine or paracrine manner, driving multiple 
intra- and inter-cellular signaling pathways, and inducing the release of endothelin-1, 
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MMP9 and glutamate. Depending on the severity of the mechanical insult, astrocyte 
reactivity may involve complex changes in phenotype and function that respond to and 
influence neuroinflammatory responses to injury as well as mechanisms of secondary 
TBI pathogenesis. Trauma also causes astrocytes to release GFAP and calcium-
binding S100B that may serve as biomarkers of TBI severity.” Each of these is an 
energy-related process, either energy release, energy creation, or energy dissipation. 
Initially, mechanical strain results in an ion flux. The rise in calcium results in ATP 
release, signaling the release of endothelin-1 (a protein), MMP9 (an enzyme), and 
glutamate (an amino acid). Correlation exists between insult level and phenotype 
function, affecting inflammation-related responses, including secondary pathogenesis.  
It is of interest to compare the energies of the biochemical processes that result 
in the creation of additional NG2-glial cells and oligodendrocytes in healthy adults, as 
compared to the demyelination that occurs in response to injury with differentiation into 
myelinating oligodendrocytes, as an example.  
 
6. Concluding Summary 
TBI is a devastating disease affecting millions of people worldwide, resulting in tens of 
thousands of deaths. Its link with brain energetics, and thus mitochondrial function, can 
help us better understand its progression and suggest clinical interventions that can 
ameliorate its most devastating symptoms. 
 General	  Summary	  
We have presented and discussed current thinking about brain energetics, 
mitochondrial function, and traumatic brain injury. While each of these areas of study 
are in themselves vast with many unanswered questions, they are closely coupled and 
represent the complexities that researchers and clinicians need to be concerned with 
and aware of – that clinical interventions involve situations where serious ambiguities 
exist, and that most of our understanding of neurophysiological processes and 
mechanisms cross multiple scales, from subcellular to multicellular to full body scale, 
and are coupled across scales. 
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 Nevertheless, specialized understanding at each scale needs to go forward 
independently of the other scales, and this can happen if the framework or control 
volume is defined properly. As progress is made at a particular scale, attempts can be 
made to couple the better-understood mechanisms to the other scales. Furthermore, an 
understanding in one discipline can lead to the same in a coupled discipline. For 
example, a better understanding of mitochondrial energetics will translate to more depth 
of understanding of TBI. 
  Here, brain energetics can be understood at the cellular level, how glia interact 
and support neurons, and how these cells convert and use energy from the nutrients 
ingested by the body. There are numerous mechanisms at the cellular level that need to 
be understood. At the subcellular level, numerous cell components work as a group to 
keep the cell functioning properly, where having sufficient energy is a core requirement, 
among others. At the center of that functioning are the mitochondria, whose internal 
workings are complex, as are how they interact with other organelles in the cell. Some 
of the internal workings of the cell are in response to inputs that originate from outside 
the cell. Similarly, these inner workings become inputs to mechanisms outside the cell. 
Some couplings and interactions operate over networks of cells, resulting in complex 
multicellular mechanisms that behave nonlinearly, switch on and off, have feedforward 
and feedback signals of biochemical, electrical and mechanical characteristics. 
Similarly, subcellular networks, in particular the mitochondrial and endoplasmic reticula, 
create couplings and exchange information and material. 
 All of these subcellular and cellular mechanisms are coupled to the larger scale 
of the entity they comprise – the human or animal body, or some smaller life form. That 
larger organism experiences and interacts with its environment, with its primary goal to 
survive and to ingest fuel in order to function, as a minimum. When the environment is 
damaging, as with TBI, the larger organism absorbs the insults at the large scale, 
converting and transmitting these all the way to the smallest scale of the organism, 
resulting in cellular and subcellular damage, triggering chemical responses coupled to 
mechanical behavior, resulting in dysfunction. This extremely complex nonlinear 
dynamic behavior is currently only understood in a piecemeal way. 
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 These mechanisms at all scales “choose” among numerous progression paths, 
some that lead to dysfunction, in particular due to ineffective energy production. 
Understanding how these “choices” are made is based on being able to formulate 
models of the mechanisms that underlie all that has been described above. These 
“choices” and mechanisms are coupled across scales, even though it is possible to 
isolate parts of the processes for in-depth study. Is there some optimality in these 
“choices” or mechanisms? If so, then dysfunction and defects are sometimes optimal 
choices for the organism, and perhaps the optimizations are energy-dependent given 
the criticality of energy production and usage. There may not be any global 
optimizations, only local sub optimizations. Understanding these optimality decisions 
provides clues and eventually paths for clinical interventions and cures for some of 
humanity’s most serious neurodegenerative diseases. 
 The review presented here is only a snapshot of current thinking and is, 
unavoidably, not a unique view of the subject matter. In the following section, a few final 
thoughts are presented. 	  Highlights	  and	  Hypotheses	  
Dynamical equations, generally, can help researchers identify factors that may be 
difficult or impossible to determine experimentally. Dynamic models can be used to 
ascertain the impact of parameter uncertainties, as well as variations in clinical 
interventions. Dynamic models can help researchers examine cell behavior beyond 
those indicated by existing experiments, and optimally design additional experiments, 
perhaps reducing their number by relying on in silico trials. 
There are numerous progression paths and possible initiators of 
neurodegenerative diseases where mitochondrial dysfunction can precede and possibly 
initiate, or occur concurrently, with an onset of pathologies. It is hypothesized that the 
path “choices” made at the cellular and subcellular levels are (sub)optimal with respect 
to energetic functioning at scales within and beyond those of the organelle and the host 
cell; they can be (sub)optimal with respect to multiple cells, and have been 
evolutionarily conserved and refined.  
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It is hypothesized that such optimal pathways can be identified via a variational 
framework (i.e., variational calculus) that identifies possible pathways, given 
morphological (mechanical), biochemical and metabolic constraints, and “selects” the 
most likely pathway. In some instances, clearly, the most likely pathway will be one that 
leads to dysfunction, for example, due to an imbalance between ROS production and 
their oxidation, or due to excessive fission. Constraints such as signaling mechanisms 
at all scales, cell and organelle morphology, feedback mechanisms, and imbalances of 
energetics and other intermediate products of mitochondrial functioning are a part of a 
possible formulation.  
Variational theoretical models are able to represent dynamics and evolution, 
including the dissipative processes that exist in all biological systems. While 
homeostasis is a target, biological systems live dynamically around homeostasis. There 
are large energy flows about equilibrium by the constituent electrical, biochemical and 
mechanical processes. These dynamic flows are representable by governing differential 
equations derived via variational methods.  
The bidirectional coupling between mitochondrial morphology (configurations) 
and bioenergetics suggests evolved optimality for efficiency, fast dynamics (fission and 
fusion), and high energy output in response to current needs.  
Physiological and pathological processes result from biochemical, morphological 
and mechanical dynamics at more than one scale, and are likely suboptimal rather than 
optimal given the many competing molecular, organelle, and cellular interests. 
Mechanical aspects of cell and organelle dynamics cannot be decoupled form the 
biochemical mechanisms of physiological and pathological processes. 
Astroglial metabolic networks linked by gap-junctions may represent an 
energetically efficient mechanism for glucose delivery to active neurons from a distal 
source rather than a nearby source that may already be in a high state of activity. 
Factors that can affect such mechanisms include capillary coverage by astrocytic 
endfeet, the density of glucose transporters in these endfeet, the astroglial metabolic 
machinery, and the strength of neuroglial interactions as witnessed by the density of 
receptors on astrocytes and the astrocytic coverage of neurons. 
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For TBI, a set of reduced order (simplified) theoretical models can be derived and 
correlated with available data, representing some of the key behaviors outlined above. 
Such equations can be used to extrapolate our understanding, and also be used to 
identify important targets for experimental investigations. Clearly identified assumptions 
can be removed as additional data becomes available and our understanding increases, 
resulting in a more complex and realistic theoretical model. Mechanical and topological 
(morphological) properties have been shown to influence biochemical and electrical 
processes. We hypothesize that the influence is significant, clearly during insult, but 
also subsequently as biochemical events unfold. 
Given the structure of mitochondrial motility – the motor/adaptor complex, and 
the various possible anchor mechanisms – it may be possible, for example, to derive 
“equivalent mechanical” models that represent chemical bonds as mechanical forces, 
and perhaps suggest mechanical equivalents to chemical signaling, and thus an 
equivalent mechanical representation of trafficking.  
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